Covalon Advances Infection Prevention and Wound Care
MISSISSAUGA, Ontario, April 15, 2026 Covalon Technologies Ltd. has reported a series of significant milestones across vascular access, infection...
AI drug discovery AI healthcare artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
MISSISSAUGA, Ontario, April 15, 2026 Covalon Technologies Ltd. has reported a series of significant milestones across vascular access, infection...
NEW YORK, April 8, 2026 Avista Healthcare Partners has announced the acquisition of Bentec Medical from Greyrock Capital Group...
SALT LAKE CITY, April 2, 2026 Co-Diagnostics, Inc. announced that its joint venture CoMira Diagnostics has received approval to...
FRANKLIN LAKES, New Jersey | January 19, 2026 — Becton, Dickinson and Company (BD) announced that the U.S. Food...
EINDHOVEN, The Netherlands | January 7, 2026 — ShanX Medtech announced the successful close of a €24 million financing...
BOSTON | January 7, 2026 — CSA Medical, a U.S.-based medical device company focused on interventional pulmonary therapies, has...
AUSTIN, Texas — December 5, 2025 — Natera has announced the acquisition of Foresight Diagnostics, a precision oncology company...
MINNEAPOLIS, Dec. 4, 2025 — Envoy Medical announced it will host a fireside chat featuring CEO Brent Lucas and...
Insulet Corporation has secured FDA 510(k) clearance for a suite of algorithm enhancements to its Omnipod® 5 Automated Insulin...
ANN ARBOR, Mich. – December 4, 2025 — ENDRA Life Sciences has released compelling new feasibility data showing that...
